Whitehawk Therapeutics
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | 0 | 0 | -1 | -5 |
EBITDA | -18,108 | -22,194 | -23,250 | -17,741 |
EBIT | -18,109 | -23,251 | -17,746 | |
Net Income | -16,640 | -22,194 | -23,251 | -17,746 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -14,529 | -22,208 | -17,234 | -15,378 |
Cash | 85,234 | 34,790 | 37,568 | 37,931 |
Basic Shares | 82,886 | 69,236 | 69,212 | 69,204 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $7,145 | $25,983 | $24,354 | $15,216 |
Gross Profit | 6,385 | -28,071 | -27,384 | -18,781 |
EBITDA | -20,517 | -64,627 | -65,365 | -58,798 |
EBIT | -20,596 | -64,820 | -65,534 | -58,957 |
Net Income | -20,596 | -63,691 | -65,765 | -60,513 |
Net Change In Cash | 7,145 | 25,983 | 24,354 | 15,216 |
Free Cash Flow | -97,985 | -61,204 | -63,635 | -50,084 |
Cash | 37,568 | 28,670 | 62,888 | 39,019 |
Basic Shares | 61,886 | 27,030 | 26,918 | 22,511 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.20 |
2026-03-31 | -$0.32 |
2025-12-31 | -$0.34 |
2025-09-30 | -$0.25 |